It’s Not East Being Green: The FDA’s Duties Under NEPA and ESA When Approving New Drugs and Biological Products
Harvard Environmental Law Review
Publication
August 5, 2024
Please visit Harvard Environmental Law Review to view this article.
Related Practices
YOU MIGHT ALSO LIKE
Thomas F. Mullin moderates theClosing the Deal: Best Practices in Environmental Due Diligence panel at FAEP'sAnnual Statewide Conference and Training Symposium in Saint Petersburg, Florida.
Bilzin Sumberg's Real Estate Partner, Joseph M. Hernandez, interviews Nitin Motwani, Managing Partner of Merrimac Ventures at Florida State University's Kislak Real Estate Market Strategies – South Florida Forum.
Kelly Ruane Melchiondo speaks on the panel entitled From Weeks to Hours: AI-Powered Initial Discovery in Construction Law at the Construction Law Institute in Orlando, Florida.